105 related articles for article (PubMed ID: 28350136)
1. All-trans retinoic acid restored the osteogenic ability of BMP9 in osteosarcoma through the p38 MAPK pathway Corrigendum in /10.3892/ijo.2019.4817.
Wu N; Li R; Meng Z; Nie M; Chen Q; He B; Deng Z; Yin L
Int J Oncol; 2017 Apr; 50(4):1363-1371. PubMed ID: 28350136
[TBL] [Abstract][Full Text] [Related]
2. All-trans retinoic acid modulates bone morphogenic protein 9-induced osteogenesis and adipogenesis of preadipocytes through BMP/Smad and Wnt/β-catenin signaling pathways.
Liu Y; Liu Y; Zhang R; Wang X; Huang F; Yan Z; Nie M; Huang J; Wang Y; Wang Y; Chen L; Yin L; He B; Deng Z
Int J Biochem Cell Biol; 2014 Feb; 47():47-56. PubMed ID: 24300824
[TBL] [Abstract][Full Text] [Related]
3. All-trans retinoic acid and COX-2 cross-talk to regulate BMP9-induced osteogenic differentiation via Wnt/β-catenin in mesenchymal stem cells.
Wang H; Hu Y; He F; Li L; Li PP; Deng Y; Li FS; Wu K; He BC
Biomed Pharmacother; 2019 Oct; 118():109279. PubMed ID: 31376651
[TBL] [Abstract][Full Text] [Related]
4. Wnt11 promotes BMP9-induced osteogenic differentiation through BMPs/Smads and p38 MAPK in mesenchymal stem cells.
Zhu JH; Liao YP; Li FS; Hu Y; Li Q; Ma Y; Wang H; Zhou Y; He BC; Su YX
J Cell Biochem; 2018 Nov; 119(11):9462-9473. PubMed ID: 30010216
[TBL] [Abstract][Full Text] [Related]
5. All-trans retinoic acid inhibits tumor growth of human osteosarcoma by activating Smad signaling-induced osteogenic differentiation.
Yang QJ; Zhou LY; Mu YQ; Zhou QX; Luo JY; Cheng L; Deng ZL; He TC; Haydon RC; He BC
Int J Oncol; 2012 Jul; 41(1):153-60. PubMed ID: 22485251
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells.
Zhang W; Deng ZL; Chen L; Zuo GW; Luo Q; Shi Q; Zhang BQ; Wagner ER; Rastegar F; Kim SH; Jiang W; Shen J; Huang E; Gao Y; Gao JL; Zhou JZ; Luo J; Huang J; Luo X; Bi Y; Su Y; Yang K; Liu H; Luu HH; Haydon RC; He TC; He BC
PLoS One; 2010 Jul; 5(7):e11917. PubMed ID: 20689834
[TBL] [Abstract][Full Text] [Related]
7. The role of Serpina3n in the reversal effect of ATRA on dexamethasone-inhibited osteogenic differentiation in mesenchymal stem cells.
Jiang HT; Deng R; Deng Y; Nie M; Deng YX; Luo HH; Yang YY; Ni N; Ran CC; Deng ZL
Stem Cell Res Ther; 2021 May; 12(1):291. PubMed ID: 34001245
[TBL] [Abstract][Full Text] [Related]
8. COX-2 promotes the osteogenic potential of BMP9 through TGF-β1/p38 signaling in mesenchymal stem cells.
Deng Y; Li L; Zhu JH; Li PP; Deng YX; Luo HH; Yang YY; He BC; Su Y
Aging (Albany NY); 2021 Apr; 13(8):11336-11351. PubMed ID: 33833129
[TBL] [Abstract][Full Text] [Related]
9. Wnt/β-Catenin Promotes the Osteoblastic Potential of BMP9 Through Down-Regulating Cyp26b1 in Mesenchymal Stem Cells.
Yao XT; Li PP; Liu J; Yang YY; Luo ZL; Jiang HT; He WG; Luo HH; Deng YX; He BC
Tissue Eng Regen Med; 2023 Aug; 20(5):705-723. PubMed ID: 37010733
[TBL] [Abstract][Full Text] [Related]
10. [p38 MAPK pathway mediated BMP9-induced osteogenetic differentiation of hPDLSCs].
Zhang Y; Hu T; Ye G; Xiang XR; Hu N
Shanghai Kou Qiang Yi Xue; 2018 Dec; 27(6):596-601. PubMed ID: 30899939
[TBL] [Abstract][Full Text] [Related]
11. Smads, p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells.
Xu DJ; Zhao YZ; Wang J; He JW; Weng YG; Luo JY
BMB Rep; 2012 Apr; 45(4):247-52. PubMed ID: 22531136
[TBL] [Abstract][Full Text] [Related]
12. Hmox1 promotes osteogenic differentiation at the expense of reduced adipogenic differentiation induced by BMP9 in C3H10T1/2 cells.
Liu X; Ji C; Xu L; Yu T; Dong C; Luo J
J Cell Biochem; 2018 Jul; 119(7):5503-5516. PubMed ID: 29377252
[TBL] [Abstract][Full Text] [Related]
13. FAK mediates BMP9-induced osteogenic differentiation via Wnt and MAPK signaling pathway in synovial mesenchymal stem cells.
Zheng W; Gu X; Sun X; Wu Q; Dan H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2641-2649. PubMed ID: 31240956
[No Abstract] [Full Text] [Related]
14. Triiodothyronine Potentiates BMP9-Induced Osteogenesis in Mesenchymal Stem Cells Through the Activation of AMPK/p38 Signaling.
Chen X; Hu Y; Jiang T; Xia C; Wang Y; Gao Y
Front Cell Dev Biol; 2020; 8():725. PubMed ID: 32850840
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein 9 overexpression reduces osteosarcoma cell migration and invasion.
Lv Z; Yang D; Li J; Hu M; Luo M; Zhan X; Song P; Liu C; Bai H; Li B; Yang Y; Chen Y; Shi Q; Weng Y
Mol Cells; 2013 Aug; 36(2):119-26. PubMed ID: 23807047
[TBL] [Abstract][Full Text] [Related]
16. CREB/Wnt10b mediates the effect of COX-2 on promoting BMP9-induced osteogenic differentiation via reducing adipogenic differentiation in mesenchymal stem cells.
Liao YP; Du WM; Hu Y; Li FS; Ma Y; Wang H; Zhu JH; Zhou Y; Li Q; Su YX; He BC
J Cell Biochem; 2019 Jun; 120(6):9572-9587. PubMed ID: 30525243
[TBL] [Abstract][Full Text] [Related]
17. Dickkopf-1 is involved in BMP9-induced osteoblast differentiation of C3H10T1/2 mesenchymal stem cells.
Lin L; Qiu Q; Zhou N; Dong W; Shen J; Jiang W; Fang J; Hao J; Hu Z
BMB Rep; 2016 Mar; 49(3):179-84. PubMed ID: 26674341
[TBL] [Abstract][Full Text] [Related]
18. RUNX1 Plays an Important Role in Mediating BMP9-Induced Osteogenic Differentiation of Mesenchymal Stem Cells Line C3H10T1/2, Murine Multi-Lineage Cells Lines C2C12 and MEFs.
Ji C; Liu X; Xu L; Yu T; Dong C; Luo J
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28644396
[TBL] [Abstract][Full Text] [Related]
19. [Corrigendum] All-trans retinoic acid restored the osteogenic ability of BMP9 in osteosarcoma through the p38 MAPK pathway.
Wu N; Li R; Meng Z; Nie M; Chen Q; He B; Deng Z; Yin L
Int J Oncol; 2019 Aug; 55(2):547. PubMed ID: 31268160
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway.
Lv Z; Wang C; Yuan T; Liu Y; Song T; Liu Y; Chen C; Yang M; Tang Z; Shi Q; Weng Y
Oncol Rep; 2014 Feb; 31(2):989-94. PubMed ID: 24337584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]